Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here